Sign Up to Download the Investor Presentation

Israel's First Pure-Play Cannabis Company

ISRACANN Biosciences (CSE: IPOT) is focused on becoming a premier, low-cost cannabis producer with three farms and cultivation licenses.

The company plans to initially target the underserved domestic market before expanding into the larger European market.



Israel has an ideal climate for low-cost production of superior quality cannabis products.

Israel has legalized exports, with Europe in close proximity, representing a significant opportunity.


Research & Development

Israel is recognized as a global center for excellence, resulting in differentiated products.

Partnerships with leading universities leverage their expertise to bring novel products to market.

Sign Up to Receive an Investor Presentation & Updates

Copyright © 2019 All Rights Reserved.

The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: